These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages. Randle DH; Zindy F; Sherr CJ; Roussel MF Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9654-9. PubMed ID: 11481442 [TBL] [Abstract][Full Text] [Related]
4. Expression of arf tumor suppressor in spermatogonia facilitates meiotic progression in male germ cells. Churchman ML; Roig I; Jasin M; Keeney S; Sherr CJ PLoS Genet; 2011 Jul; 7(7):e1002157. PubMed ID: 21811412 [TBL] [Abstract][Full Text] [Related]
5. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements. D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322 [TBL] [Abstract][Full Text] [Related]
6. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1). Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971 [TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-mediated protein degradation and methylation-induced gene silencing cooperate in the inactivation of the INK4/ARF locus in Burkitt lymphoma cell lines. Roberti A; Rizzolio F; Lucchetti C; de Leval L; Giordano A Cell Cycle; 2011 Jan; 10(1):127-34. PubMed ID: 21200153 [TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of mammalian cells expressing the Arf promoter during eye development. Iqbal NS; Xu L; Devitt CC; Skapek SX Biotechniques; 2014 May; 56(5):239-49. PubMed ID: 24806224 [TBL] [Abstract][Full Text] [Related]
10. Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non-small cell lung cancer. Gamell C; Gulati T; Levav-Cohen Y; Young RJ; Do H; Pilling P; Takano E; Watkins N; Fox SB; Russell P; Ginsberg D; Monahan BJ; Wright G; Dobrovic A; Haupt S; Solomon B; Haupt Y Sci Signal; 2017 Jan; 10(461):. PubMed ID: 28074012 [TBL] [Abstract][Full Text] [Related]
11. Expression of the Arf tumor suppressor gene is controlled by Tgfbeta2 during development. Freeman-Anderson NE; Zheng Y; McCalla-Martin AC; Treanor LM; Zhao YD; Garfin PM; He TC; Mary MN; Thornton JD; Anderson C; Gibbons M; Saab R; Baumer SH; Cunningham JM; Skapek SX Development; 2009 Jun; 136(12):2081-9. PubMed ID: 19465598 [TBL] [Abstract][Full Text] [Related]
12. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation. Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918 [TBL] [Abstract][Full Text] [Related]
13. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. Damalas A; Kahan S; Shtutman M; Ben-Ze'ev A; Oren M EMBO J; 2001 Sep; 20(17):4912-22. PubMed ID: 11532955 [TBL] [Abstract][Full Text] [Related]
14. Identification of Liu YT; Xu L; Bennett L; Hooks JC; Liu J; Zhou Q; Liem P; Zheng Y; Skapek SX Mol Cancer Res; 2019 Sep; 17(9):1854-1866. PubMed ID: 31189690 [TBL] [Abstract][Full Text] [Related]
15. A distant, cis-acting enhancer drives induction of Arf by Tgfβ in the developing eye. Zheng Y; Devitt C; Liu J; Mei J; Skapek SX Dev Biol; 2013 Aug; 380(1):49-57. PubMed ID: 23665474 [TBL] [Abstract][Full Text] [Related]
16. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis. D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676 [TBL] [Abstract][Full Text] [Related]
17. Toxicology and carcinogenesis study of glycidol (CAS No. 556-52-5) in genetically modified haploinsufficient p16(Ink4a)/p19(Arf) mice (gavage study). National Toxicology Program Natl Toxicol Program Genet Modif Model Rep; 2007 Nov; (13):1-81. PubMed ID: 18784757 [TBL] [Abstract][Full Text] [Related]
18. Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Keller C; Arenkiel BR; Coffin CM; El-Bardeesy N; DePinho RA; Capecchi MR Genes Dev; 2004 Nov; 18(21):2614-26. PubMed ID: 15489287 [TBL] [Abstract][Full Text] [Related]
19. The regulation of INK4/ARF in cancer and aging. Kim WY; Sharpless NE Cell; 2006 Oct; 127(2):265-75. PubMed ID: 17055429 [TBL] [Abstract][Full Text] [Related]
20. Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia. Bardeesy N; Morgan J; Sinha M; Signoretti S; Srivastava S; Loda M; Merlino G; DePinho RA Mol Cell Biol; 2002 Jan; 22(2):635-43. PubMed ID: 11756558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]